端粒
端粒酶
生物
染色体外DNA
端粒结合蛋白
DNA
细胞生物学
DNA复制
癌变
基因
遗传学
分子生物学
癌症研究
DNA结合蛋白
基因组
转录因子
作者
Jeremy D. Henson,Axel A. Neumann,Thomas R. Yeager,Roger R. Reddel
出处
期刊:Oncogene
[Springer Nature]
日期:2002-01-21
卷期号:21 (4): 598-610
被引量:661
标识
DOI:10.1038/sj.onc.1205058
摘要
Some immortalized mammalian cell lines and tumors maintain or increase the overall length of their telomeres in the absence of telomerase activity by one or more mechanisms referred to as alternative lengthening of telomeres (ALT). Characteristics of human ALT cells include great heterogeneity of telomere size (ranging from undetectable to abnormally long) within individual cells, and ALT-associated PML bodies (APBs) that contain extrachromosomal telomeric DNA, telomere-specific binding proteins, and proteins involved in DNA recombination and replication. Activation of ALT during immortalization involves recessive mutations in genes that are as yet unidentified. Repressors of ALT activity are present in normal cells and some telomerase-positive cells. Telomere length dynamics in ALT cells suggest a recombinational mechanism. Inter-telomeric copying occurs, consistent with a mechanism in which single-stranded DNA at one telomere terminus invades another telomere and uses it as a copy template resulting in net increase in telomeric sequence. It is possible that t-loops, linear and/or circular extrachromosomal telomeric DNA, and the proteins found in APBs, may be involved in the mechanism. ALT and telomerase activity can co-exist within cultured cells, and within tumors. The existence of ALT adds some complexity to proposed uses of telomere-related parameters in cancer diagnosis and prognosis, and poses challenges for the design of anticancer therapeutics designed to inhibit telomere maintenance.
科研通智能强力驱动
Strongly Powered by AbleSci AI